Snowball logo
logo
ALGN_logo

Align Technology, Inc. ORD SHS

₽39,800.00₽0.00  (0%)
Estimate
P/E
0.4
EPS
445.186
Beta
-0.002
Growth
Revenue, YoY
4.99%
Net income, YoY
-12.54%
FCF, YoY
46.14%
Forecast
P/E (FWD)
13.2
EPS (FWD)
12.505
About the company
Ticker
ALGN-RM
ISIN
US0162551016
Country
Other
Sector (GICS)
Healthcare
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Frequently asked questions

What sector does Align Technology, Inc. ORD SHS (ALGN-RM) operate in?

Align Technology, Inc. ORD SHS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Align Technology, Inc. ORD SHS (ALGN-RM) current stock price?

As of the latest data, Align Technology, Inc. ORD SHS stock price is RUB 39,800.00, with a previous close of RUB 39,800.00.

What is Align Technology, Inc. ORD SHS (ALGN-RM) current market capitalization?

Align Technology, Inc. ORD SHS market cap is approximately 11.71 billion.

What is Align Technology, Inc. ORD SHS (ALGN-RM) Earnings Per Share (EPS)?

The trailing EPS is RUB 445.19, and the forward EPS is RUB 12.51.

What is Align Technology, Inc. ORD SHS (ALGN-RM) Price-to-Earnings (P/E) ratio?

Align Technology, Inc. ORD SHS current P/E ratio is 0.37, with a forward P/E of 13.19.

What is Align Technology, Inc. ORD SHS (ALGN-RM) EBITDA?

Align Technology, Inc. ORD SHS EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.13 billion.

Does Align Technology, Inc. ORD SHS (ALGN-RM) pay dividends?

No. Align Technology, Inc. ORD SHS does not pay a dividend.

How did Align Technology, Inc. ORD SHS (ALGN-RM) perform in its most recent earnings report?

In the last report (June 30, 2026), Align Technology, Inc. ORD SHS posted an EPS surprise of -1.44% and a revenue surprise of 7,775.18%.

When is Align Technology, Inc. ORD SHS (ALGN-RM) next earnings report?

Align Technology, Inc. ORD SHS is expected to release its next earnings report on September 30, 2026.

What is Align Technology, Inc. ORD SHS (ALGN-RM) beta (volatility) score?

Align Technology, Inc. ORD SHS has a beta of -0.002, indicating lower volatility than the overall market.